Table 2 Inclusion and exclusion study criteria
Inclusion criteria | Exclusion criteria |
|---|---|
Children aged 6 months to < 10 years | Children <  6 months or ≥ 10 years |
Hb >  5 mg/dl | Hb ≤ 5 mg/dL, or Hb < 6 mg/dL with signs of clinical decompensation |
Sleeps in cluster > 90% of nights during any given month | Sleeps in cluster < 90% of nights during any given month |
No plans for extended travel (> 1 month) outside of home during study | Plans for extended travel (> 1 month) outside of home during study |
Not participating in another clinical trial investigating a vaccine, drug, medical device, or a medical procedure during the trial | Participating or planned participation in another clinical trial investigating a vaccine, drug, medical device, or a medical procedure during the trial |
Provision of informed consent form (ICF) signed by the parent(s) or guardian | No provision of ICF signed by the parent(s) or guardian |
Children not on regular malaria prophylaxis*** | Children on regular malaria prophylaxis*** |
Willingness to take Artemether-Lumefantrine (AL) and no history of hypersensitivity to AL | Unwillingness or refusal to take AL and history of AL hypersensitivity |